ASCEND: A Study of Cardiovascular Events iN Diabetes

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to determine whether 100mg daily aspirin versus placebo and/or supplementation with 1 gram daily omega-3 fatty acids or placebo prevents "serious vascular events" (i.e. non-fatal heart attack, non-fatal stroke or transient ischaemic attack, or death from vascular causes) in patients with diabetes who are not known to have occlusive arterial disease and to assess the effects on serious...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 December 2015.

1 Mar 2005 24 Aug 2005 1 Sep 2017 Unavailable 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Factorial Assignment

Contacts

  • Jill Barton Phone: 44 1865 743814 Email: jill.barton@ctsu.ox.ac.uk

    louise.bowman@ctsu.ox.ac.uk